Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous sodium ascorbate for hospitalized lower limb cellulitis
ACTRN12610000762055Phase 2Terminated
- Sponsor
- Biological Therapies
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cellulitis comparing Sodium ascorbate + standard care with Placebo + standard care (2 arms). Primary endpoints: Maximum C-reactive protein and Cellulitis Visual Score. Started Aug 2011; status: terminated.
02
Drugs
sodium ascorbate
03
Conditions
cellulitis
Beyond the preview
Go deeper on ACTRN12610000762055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000762055.